CJC-1295 Without DAC + Ipamorelin Blend
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
CJC-1295 Without DAC 10mg+Ipamorelin 10mg blend
CJC-1295 Without DAC + Ipamorelin ,Modified GRF(1-29) + Ipamorelin , CJC-1295 No DAC Blend , Mod GRF(1-29) / Ipamorelin Peptide Blend,Synthetic GHRH Analogue and Peptide Research Blend
Contact us for current batch testing data on this specification.

CJC-1295 Without DAC + Ipamorelin is a synthetic peptide blend consisting of Modified GRF(1-29) and Ipamorelin. Modified GRF(1-29), also known as CJC-1295 Without DAC, is a 29-amino-acid peptide analogue derived from the N-terminal region of human growth hormone-releasing hormone (GHRH). The peptide contains specific amino acid modifications including D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27 compared with native GRF(1-29). Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. This peptide blend is supplied as a research material for peptide structure studies, analytical characterization, and laboratory research applications.
Overview
CJC-1295 Without DAC 10mg + Ipamorelin 10mg is a synthetic peptide blend containing Modified GRF(1-29) and Ipamorelin, designed for laboratory research and analytical characterization.
Composition and Molecular Identity
CJC-1295 Without DAC + Ipamorelin is a synthetic peptide blend consisting of two chemically defined peptide components: Modified GRF(1-29) and Ipamorelin. CJC-1295 Without DAC is also known as Modified GRF(1-29), a 29-amino-acid synthetic analogue derived from the N-terminal region of human growth hormone-releasing hormone (GHRH). Ipamorelin is a synthetic pentapeptide with a defined amino acid sequence and is commonly studied as a peptide research compound.
Peptide Structure Information
Modified GRF(1-29) is a modified GHRH(1-29) peptide containing four amino acid substitutions compared with the native peptide sequence. The sequence of CJC-1295 Without DAC is: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 The structural modifications include D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27.
Research Background
CJC-1295 Without DAC represents the DAC-free form of the modified GHRH analogue commonly described as Modified GRF(1-29). The peptide differs from the DAC-containing analogue by the absence of the additional drug affinity complex modification. Research information related to this peptide focuses on molecular structure, peptide characterization, and GHRH analogue studies.
Analytical Characterization
CJC-1295 Without DAC and Ipamorelin can be characterized using analytical techniques including high-performance liquid chromatography (HPLC), mass spectrometry (MS), and molecular identity analysis. Analytical characterization provides information regarding peptide identity, purity profile, and physicochemical properties for laboratory research purposes.
Research Material Description
CJC-1295 Without DAC 10mg + Ipamorelin 10mg is supplied as a lyophilized peptide research material. The blend contains two synthetic peptide components intended for laboratory studies involving peptide analysis, structural investigation, and analytical research.
Key Highlights
- Contains Modified GRF(1-29) and Ipamorelin
- CJC-1295 Without DAC corresponds to Modified GRF(1-29)
- 29-amino-acid synthetic GHRH analogue component
- Ipamorelin is a synthetic pentapeptide research compound
- Supplied as a lyophilized peptide research blend
Safety & Side Effects
CJC-1295 Without DAC + Ipamorelin is a synthetic peptide blend consisting of Modified GRF(1-29) and Ipamorelin. Modified GRF(1-29), also known as CJC-1295 Without DAC, is a 29-amino-acid peptide analogue derived from the N-terminal region of human growth hormone-releasing hormone (GHRH). The peptide contains specific amino acid modifications including D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27 compared with native GRF(1-29). Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. This peptide blend is supplied as a research material for peptide structure studies, analytical characterization, and laboratory research applications. When used in research, CJC-1295 Without DAC 10mg + IPA 10mg should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published cjc-1295 without dac 10mg + ipa 10mg side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for growth hormone secretagogue activity readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for CJC-1295 Without DAC 10mg + IPA 10mg; it is supplied strictly for laboratory research. Reported cjc-1295 without dac 10mg + ipa 10mg dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document cjc-1295 without dac 10mg + ipa 10mg dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (the specifications listed on the product page). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
How to Order
Inquiry
Send product code, required quantity and research specifications.
Quality
Analytical documentation available upon request.
COA
Each batch is tested according to analytical specifications.
Delivery
Discreet, tracked worldwide shipping.
Specifications
| Product name | CJC-1295 Without DAC 10mg+Ipamorelin 10mg blend |
|---|---|
| Product code | CP20 |
| Specification | 20mg*10vials |
| Purity | ≥99% |
| Category | Synthetic Peptide Blend |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized peptide under appropriate laboratory storage conditions. Protect from moisture and avoid repeated freeze-thaw cycles. Storage conditions should follow laboratory handling requirements.
Product Information Q&A
What is CJC-1295 Without DAC + Ipamorelin?
CJC-1295 Without DAC + Ipamorelin is a synthetic peptide blend containing Modified GRF(1-29) and Ipamorelin as two separate peptide research components.
What is CJC-1295 Without DAC also known as?
CJC-1295 Without DAC is commonly identified as Modified GRF(1-29), a synthetic 29-amino-acid peptide analogue.
Additional information
| Dosage | 10mg + 10mg, 5mg + 5mg |
|---|

